Mind Medicine (MindMed) Inc. (MNMD) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/15/26
Definium Therapeutics Common Shares to Trade under New Nasdaq Ticker Symbol “DFTX” Effective January 15, 2026Business Wire • 01/13/26
MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026Business Wire • 01/12/26
MNMD Stock Up More Than 100% in 6 Months: What's in Store for 2026?Zacks Investment Research • 12/29/25
5 High-Risk, High-Reward Biotech Breakthrough Stocks to Watch in 2026Zacks Investment Research • 12/16/25
Mind Medicine (MindMed) Inc. Announces Closing of Approximately $259 Million Public Offering, Including Full Exercise of the Underwriters' Option to Purchase Additional SharesBusiness Wire • 11/03/25
Mind Medicine (MindMed) Inc. Announces Pricing of $225 Million Public OfferingBusiness Wire • 10/30/25
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)Business Wire • 09/19/25
Journal of the American Medical Association (JAMA) Publishes Results from First-Ever Randomized, Placebo-Controlled Clinical Trial Assessing the Dose-Dependent Efficacy of MM120 (Lysergide D-Tartrate, LSD) in Generalized Anxiety Disorder (GAD)Business Wire • 09/04/25
If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have TodayThe Motley Fool • 08/12/25